About
Technology
Issues
FAQ
Links
Official Page
The ‘obesity paradox’ in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.